Allspring Global Investments Holdings, LLC Agenus Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$1.31 - $2.04 $26,927 - $41,932	-20,555 Reduced 64.3%	11,411 $18,000
Q1 2023 Apr 13, 2023	SELL	$1.45 - $2.95 $24,307 - $49,453	-16,764 Reduced 34.4%	31,966 $48,000
Q4 2022 Jan 23, 2023	SELL	$2.02 - $3.25 $47,142 - $75,848	-23,338 Reduced 32.38%	48,730 $0
Q3 2022 Oct 26, 2022	SELL	$1.96 - $3.14 $740 - $1,186	-378 Reduced 0.52%	72,068 $147,000
Q2 2022 Jul 25, 2022	SELL	$1.3 - $2.64 $85,829 - $174,300	-66,023 Reduced 47.68%	72,446 $140,000
Q1 2022 May 02, 2022	BUY	$2.35 - $3.47 $106,168 - $156,767	45,178 Added 48.43%	138,469 $340,000
Q4 2021 Jan 28, 2022	BUY	$2.92 - $5.74 $272,409 - $535,490	93,291 New	93,291 $300,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account